Does acipimox affect postprandial suppression of endogenous glucose production in healthy adults?

Acipimox is a drug that reduces free fatty acids, which are fats circulating in the blood. After a meal, the liver normally slows down its glucose production to help keep blood sugar stable. In this case, even though acipimox helped lower blood sugar and raised insulin, the liver still reduced its glucose output the same way it normally would. That means something else — perhaps muscle uptake of glucose or other metabolic changes — might be responsible for the better blood sugar control, not the liver’s behavior.

We only reviewed one assertion, and no studies contradicted it. But because the total number of studies analyzed is very small, we can’t say this applies broadly or that the mechanism is fully understood. The evidence we’ve reviewed so far leans toward acipimox not altering the liver’s post-meal glucose suppression, but more research would be needed to confirm this pattern across different groups or conditions.

In everyday terms: taking acipimox helps lower blood sugar after meals, but it doesn’t seem to do so by telling the liver to make less glucose. Something else is likely going on.